Compare ServiceNow Inc (NOW) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ServiceNow Inc vs GeneDx Holdings Corp — how do they compare? ServiceNow Inc trades at $122.25 (market cap $129.17B), while GeneDx Holdings Corp trades at $81 (market cap $2.45B). The key difference: ServiceNow Inc is far larger — about 52.7× GeneDx Holdings Corp's market cap. Which is the better fit depends on your goals.
| NOW | WGS | |
|---|---|---|
Market Cap | $129.17B | $2.45B |
Sector | Technology | Technology |
52-Week High | $192.23 | $167.51 |
52-Week Low | $83.00 | $34.51 |
Enterprise Value | $132.96B | $2.49B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ServiceNow (NOW) trades at $127.54, up 0.08% with a bullish technical outlook despite overbought RSI readings. The company demonstrates strong fundamentals with 2025 revenue of $13.28B and net income of $1.75B, though valuation metrics remain elevated with a P/E of 79.71. Recent earnings show mixed results with Q2 2026 beating expectations but Q1 2026 missing, while analyst sentiment remains overwhelmingly positive with 87% buy ratings.
ServiceNow presents a compelling growth story with expanding profit margins and strong cash flow generation, though premium valuation and competitive pressures warrant caution. The stock's 41% surge in May 2026 reflects market recognition of AI-driven opportunities, but investors should monitor execution risks and the sustainability of current growth rates amid economic uncertainties.
GeneDx Holdings Corp (WGS) trades at $82.39, up 5.79% in the past 24 hours, with a bullish technical signal and strong analyst support. The company reported Q2 2026 revenue of $114.4 million, beating guidance, and returned to adjusted profitability earlier than expected. However, net income remains negative at -$106 million for 2026, and the stock faces class action lawsuits with an August 3, 2026 deadline.
Outlook is mixed: bullish technicals and analyst consensus suggest upside to the $90 price target, but fundamental weaknesses and legal risks pose significant challenges. Investment opportunity hinges on sustained revenue growth and margin improvement, while risks include profitability pressures and litigation outcomes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ServiceNow Inc
ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management (ITSM), expanded within the IT function, and more recently directed its workflow automation logic to functional areas beyond IT, notably customer service, HR service delivery, and security operations. ServiceNow also offers an application development platform as a service (PaaS).
Read more on NOW →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
